Updated: 23-Jan-26 09:09 ET
Ends: 03-Feb-26 | Co: AKTS
Aktis Oncology (Nasdaq) | Clinical-stage company developing next-generation radiopharmaceuticals to target a broader range of solid tumors | Opened: 09-Jan-26, $27.00 | Priced: $18.00 | Underwriters: Lead: J.P. Morgan, BofA Securities, Leerink Partners and TD Cowen |
Ends: 16-Feb-26 | Co: BTGO
BitGo Holdings (NYSE) | Global digital asset infrastructure company providing custody, wallets, trading, staking, and settlement services to institutions and investors | Opened: 22-Jan-26, $22.43 | Priced: $18.00 | Underwriters: Lead: Goldman Sachs & Co. LLC |